Annual Total Assets
$640.55 M
+$277.98 M+76.67%
December 31, 2023
Summary
- As of February 7, 2025, MDGL annual total assets is $640.55 million, with the most recent change of +$277.98 million (+76.67%) on December 31, 2023.
- During the last 3 years, MDGL annual total assets has risen by +$353.55 million (+123.19%).
- MDGL annual total assets is now at all-time high.
Performance
MDGL Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Assets
$1.07 B
-$26.52 M-2.41%
September 30, 2024
Summary
- As of February 7, 2025, MDGL quarterly total assets is $1.07 billion, with the most recent change of -$26.52 million (-2.41%) on September 30, 2024.
- Over the past year, MDGL quarterly total assets has dropped by -$26.52 million (-2.41%).
- MDGL quarterly total assets is now -2.41% below its all-time high of $1.10 billion, reached on June 30, 2024.
Performance
MDGL Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Assets Formula
Total Assets = Current Assets + Non-Current Assets
MDGL Total Assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +76.7% | -2.4% |
3 y3 years | +123.2% | -2.4% |
5 y5 years | +32.0% | -2.4% |
MDGL Total Assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +134.3% | -2.4% | +576.5% |
5 y | 5-year | at high | +134.3% | -2.4% | +576.5% |
alltime | all time | at high | >+9999.0% | -2.4% | >+9999.0% |
Madrigal Pharmaceuticals Total Assets History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $1.07 B(-2.4%) |
Jun 2024 | - | $1.10 B(+1.6%) |
Mar 2024 | - | $1.08 B(+69.0%) |
Dec 2023 | $640.55 M(+76.7%) | $640.55 M(+169.2%) |
Sep 2023 | - | $237.96 M(-21.3%) |
Jun 2023 | - | $302.46 M(-9.0%) |
Mar 2023 | - | $332.45 M(-8.3%) |
Dec 2022 | $362.57 M(+32.6%) | $362.57 M(+128.5%) |
Sep 2022 | - | $158.64 M(-26.7%) |
Jun 2022 | - | $216.39 M(-2.8%) |
Mar 2022 | - | $222.66 M(-18.5%) |
Dec 2021 | $273.33 M(-4.8%) | $273.33 M(-10.3%) |
Sep 2021 | - | $304.70 M(-7.1%) |
Jun 2021 | - | $327.95 M(+5.9%) |
Mar 2021 | - | $309.73 M(+7.9%) |
Dec 2020 | $287.00 M(-35.1%) | $287.00 M(-15.5%) |
Sep 2020 | - | $339.62 M(-12.6%) |
Jun 2020 | - | $388.39 M(-5.6%) |
Mar 2020 | - | $411.46 M(-6.9%) |
Dec 2019 | $442.06 M(-8.9%) | $442.06 M(-3.1%) |
Sep 2019 | - | $456.25 M(-2.9%) |
Jun 2019 | - | $469.82 M(-2.0%) |
Mar 2019 | - | $479.56 M(-1.2%) |
Dec 2018 | $485.43 M(+152.4%) | $485.43 M(-0.8%) |
Sep 2018 | - | $489.55 M(-0.4%) |
Jun 2018 | - | $491.53 M(+167.9%) |
Mar 2018 | - | $183.48 M(-4.6%) |
Dec 2017 | $192.31 M(+366.7%) | $192.31 M(+206.1%) |
Sep 2017 | - | $62.83 M(-7.7%) |
Jun 2017 | - | $68.07 M(+68.7%) |
Mar 2017 | - | $40.36 M(-2.1%) |
Dec 2016 | $41.21 M(>+9900.0%) | $41.21 M(-0.7%) |
Sep 2016 | - | $41.51 M(-7.6%) |
Jun 2016 | - | $44.94 M(-15.2%) |
Mar 2016 | - | $52.97 M(>+9900.0%) |
Dec 2015 | $363.60 K(-99.6%) | $363.60 K(-99.6%) |
Sep 2015 | - | $91.01 M(-10.4%) |
Jun 2015 | - | $101.54 M(+27.9%) |
Mar 2015 | - | $79.39 M(-21.1%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2014 | $100.67 M(+5.7%) | $100.67 M(-18.6%) |
Sep 2014 | - | $123.66 M(+6.6%) |
Jun 2014 | - | $115.95 M(+41.1%) |
Mar 2014 | - | $82.18 M(-13.7%) |
Dec 2013 | $95.20 M(-7.6%) | $95.20 M(+68.0%) |
Sep 2013 | - | $56.66 M(-23.3%) |
Jun 2013 | - | $73.92 M(-21.1%) |
Mar 2013 | - | $93.70 M(-9.0%) |
Dec 2012 | $103.02 M(+143.4%) | $103.02 M(+78.8%) |
Sep 2012 | - | $57.61 M(+22.2%) |
Jun 2012 | - | $47.16 M(-21.2%) |
Mar 2012 | - | $59.84 M(+41.4%) |
Dec 2011 | $42.32 M(-21.7%) | $42.32 M(-21.4%) |
Sep 2011 | - | $53.87 M(-17.9%) |
Jun 2011 | - | $65.62 M(+52.9%) |
Mar 2011 | - | $42.93 M(-20.6%) |
Dec 2010 | $54.07 M(+10.5%) | $54.07 M(-6.6%) |
Sep 2010 | - | $57.88 M(+10.1%) |
Jun 2010 | - | $52.55 M(-16.0%) |
Mar 2010 | - | $62.54 M(+27.9%) |
Dec 2009 | $48.91 M(-49.7%) | $48.91 M(-15.0%) |
Sep 2009 | - | $57.56 M(-15.6%) |
Jun 2009 | - | $68.20 M(-25.7%) |
Mar 2009 | - | $91.75 M(-5.7%) |
Dec 2008 | $97.25 M(-20.7%) | $97.25 M(+7.1%) |
Sep 2008 | - | $90.76 M(+4.3%) |
Jun 2008 | - | $87.06 M(-18.4%) |
Mar 2008 | - | $106.64 M(-13.1%) |
Dec 2007 | $122.65 M(+123.9%) | $122.65 M(+119.0%) |
Sep 2007 | - | $56.01 M(-21.8%) |
Jun 2007 | - | $71.60 M(-16.0%) |
Mar 2007 | - | $85.20 M(+55.5%) |
Dec 2006 | $54.79 M(-23.1%) | $54.79 M(-17.4%) |
Sep 2006 | - | $66.34 M(-6.8%) |
Dec 2005 | $71.21 M(-46.1%) | $71.21 M(-39.9%) |
Mar 2005 | - | $118.47 M |
Dec 2004 | $132.02 M(+64.2%) | - |
Dec 2003 | $80.39 M(+2798.9%) | - |
Dec 2001 | $2.77 M | - |
FAQ
- What is Madrigal Pharmaceuticals annual total assets?
- What is the all time high annual total assets for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals annual total assets year-on-year change?
- What is Madrigal Pharmaceuticals quarterly total assets?
- What is the all time high quarterly total assets for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals quarterly total assets year-on-year change?
What is Madrigal Pharmaceuticals annual total assets?
The current annual total assets of MDGL is $640.55 M
What is the all time high annual total assets for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high annual total assets is $640.55 M
What is Madrigal Pharmaceuticals annual total assets year-on-year change?
Over the past year, MDGL annual total assets has changed by +$277.98 M (+76.67%)
What is Madrigal Pharmaceuticals quarterly total assets?
The current quarterly total assets of MDGL is $1.07 B
What is the all time high quarterly total assets for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high quarterly total assets is $1.10 B
What is Madrigal Pharmaceuticals quarterly total assets year-on-year change?
Over the past year, MDGL quarterly total assets has changed by -$26.52 M (-2.41%)